首页 > 最新文献

Gastroenterology Research and Practice最新文献

英文 中文
Astaxanthin Alleviates Inflammatory Response in Neonatal Necrotizing Enterocolitis Rats by Regulating NOD2/TLR4 Pathway. 虾青素通过调节 NOD2/TLR4 通路缓解新生儿坏死性小肠结肠炎大鼠的炎症反应
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-03-27 eCollection Date: 2023-01-01 DOI: 10.1155/2023/6078308
Xuandong Zhang, Yujia Luo, Rui Gu, Zhou Jiang

Background: Necrotizing enterocolitis (NEC) is often associated with exaggerated activation of inflammatory response. Astaxanthin has been shown in studies to have a positive and advantageous effect on anti-inflammatory response. Hence, it is of great significance to study the protective effect of astaxanthin in NEC disease and its molecular mechanism.

Objective: The present study was to investigate whether astaxanthin attenuates NEC rats and to explore its potential mechanism. Material and Methods. Hematoxylin-eosin staining was used to observe the pathological change of the intestinal tissue in NEC rats. Subsequently, we determined the anti-oxidative stress, anti-apoptosis, and anti-inflammation in astaxanthin with enzyme-linked immunosorbent assay kits, TUNEL staining, western blot, and immunohistochemistry assay. Furthermore, we added nucleotide-binding oligomerization domain 2 (NOD2) inhibitor to certify the molecular pathway of the astaxanthin in NEC rats.

Results: Astaxanthin improved the pathological changes of the intestinal tissues. It restrained inflammation, oxidative stress, and protected cells from apoptosis in the intestinal tissue and serum of the NEC rats. Moreover, astaxanthin enhanced NOD2, whereas it suppressed toll-like receptor 4 (TLR4), nuclear factor-κB (NF-κB) pathway-related proteins. Apart from that, the NOD2 inhibitor offset the protective effect of the astaxanthin towards the NEC rats.

Conclusion: The present study indicated that astaxanthin alleviated oxidative stress, inflammatory response, and apoptosis in NEC rats by enhancing NOD2 and inhibiting TLR4 pathway.

背景:坏死性小肠结肠炎(NEC坏死性小肠结肠炎(NEC)通常与炎症反应的过度激活有关。研究表明,虾青素对抗炎反应具有积极和有利的作用。因此,研究虾青素对NEC疾病的保护作用及其分子机制具有重要意义:本研究旨在探讨虾青素是否能减轻NEC大鼠的病情,并探索其潜在机制。材料和方法。采用血红素-伊红染色法观察NEC大鼠肠道组织的病理变化。随后,我们通过酶联免疫吸附试验、TUNEL染色、Western印迹和免疫组化测定虾青素的抗氧化应激、抗凋亡和抗炎作用。此外,我们还添加了核苷酸结合寡聚化结构域2(NOD2)抑制剂,以证实虾青素在NEC大鼠中的分子途径:结果:虾青素改善了肠道组织的病理变化。结果:虾青素改善了NEC大鼠肠道组织的病理变化,抑制了肠道组织和血清中的炎症、氧化应激和细胞凋亡。此外,虾青素还能增强 NOD2,而抑制收费样受体 4 (TLR4)、核因子-κB (NF-κB)通路相关蛋白。此外,NOD2 抑制剂抵消了虾青素对 NEC 大鼠的保护作用:本研究表明,虾青素通过增强NOD2和抑制TLR4通路,减轻了NEC大鼠的氧化应激、炎症反应和细胞凋亡。
{"title":"Astaxanthin Alleviates Inflammatory Response in Neonatal Necrotizing Enterocolitis Rats by Regulating NOD2/TLR4 Pathway.","authors":"Xuandong Zhang, Yujia Luo, Rui Gu, Zhou Jiang","doi":"10.1155/2023/6078308","DOIUrl":"10.1155/2023/6078308","url":null,"abstract":"<p><strong>Background: </strong>Necrotizing enterocolitis (NEC) is often associated with exaggerated activation of inflammatory response. Astaxanthin has been shown in studies to have a positive and advantageous effect on anti-inflammatory response. Hence, it is of great significance to study the protective effect of astaxanthin in NEC disease and its molecular mechanism.</p><p><strong>Objective: </strong>The present study was to investigate whether astaxanthin attenuates NEC rats and to explore its potential mechanism. <i>Material and Methods.</i> Hematoxylin-eosin staining was used to observe the pathological change of the intestinal tissue in NEC rats. Subsequently, we determined the anti-oxidative stress, anti-apoptosis, and anti-inflammation in astaxanthin with enzyme-linked immunosorbent assay kits, TUNEL staining, western blot, and immunohistochemistry assay. Furthermore, we added nucleotide-binding oligomerization domain 2 (NOD2) inhibitor to certify the molecular pathway of the astaxanthin in NEC rats.</p><p><strong>Results: </strong>Astaxanthin improved the pathological changes of the intestinal tissues. It restrained inflammation, oxidative stress, and protected cells from apoptosis in the intestinal tissue and serum of the NEC rats. Moreover, astaxanthin enhanced NOD2, whereas it suppressed toll-like receptor 4 (TLR4), nuclear factor-<i>κ</i>B (NF-<i>κ</i>B) pathway-related proteins. Apart from that, the NOD2 inhibitor offset the protective effect of the astaxanthin towards the NEC rats.</p><p><strong>Conclusion: </strong>The present study indicated that astaxanthin alleviated oxidative stress, inflammatory response, and apoptosis in NEC rats by enhancing NOD2 and inhibiting TLR4 pathway.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"6078308"},"PeriodicalIF":2.0,"publicationDate":"2023-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070044/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9626502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sedation Is Associated with Higher Polyp and Adenoma Detection Rates during Colonoscopy: A Retrospective Cohort Study. 镇静与结肠镜检查中更高的息肉和腺瘤检出率有关:一项回顾性队列研究
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-02-18 eCollection Date: 2023-01-01 DOI: 10.1155/2023/1172478
Chenghu Xu, Dehua Tang, Ying Xie, Muhan Ni, Min Chen, Yonghua Shen, Xiaotan Dou, Lin Zhou, Guifang Xu, Lei Wang, Ying Lv, Shu Zhang, Xiaoping Zou

Background and aims: Currently sedation is a common practice in colonoscopy to reduce pain of patients and improve the operator satisfaction, whereas its impact on examination quality, especially adenoma detection rate (ADR) is still controversial. Thus, we aimed to investigate the association of sedation with ADR.

Methods: Consecutive patients receiving colonoscopy between January 2017 and January 2020 at the Nanjing Drum Tower Hospital, Nanjing, China, were collected. Univariate and multivariate logistic regression models were performed to investigate the association between sedation and ADR. Subgroup analysis and propensity score matching (PSM) analysis, as sensitivity analysis, were performed to validate the independent effect.

Results: The ADR was significantly higher in cases with sedation (ADR: 36.9% vs. 29.1%, odds ratio [OR]: 1.42, 95% confidence interval [CI]: 1.31-1.55, P < 0.001). Multivariate analysis showed that the sedation was an independent factor associated with ADR (OR: 1.49, 95% CI: 1.35-1.65, P < 0.001). The effect was consistent in subgroup analyses (P > 0.05) and PSM analysis (ADR: 37.6% vs. 29.1%, OR: 1.47, 95% CI: 1.33-1.63, P < 0.001).

Conclusion: Sedation was associated with a higher polyp and ADR s during colonoscopy, which can promote the quality of colonoscopy.

背景和目的:目前,镇静是结肠镜检查的常用方法,可减轻患者疼痛并提高操作者满意度,但镇静对检查质量,尤其是腺瘤检出率(ADR)的影响仍存在争议。因此,我们旨在研究镇静与 ADR 的关系:方法:收集2017年1月至2020年1月期间在中国南京鼓楼医院接受结肠镜检查的连续患者。采用单变量和多变量逻辑回归模型研究镇静与ADR之间的关系。作为敏感性分析,还进行了亚组分析和倾向得分匹配(PSM)分析,以验证其独立效应:结果:使用镇静剂的病例的 ADR 明显更高(ADR:36.9% 对 29.1%,几率比 [OR]:1.42,95% 置信区间):1.42,95% 置信区间 [CI]:1.31-1.55, P < 0.001).多变量分析显示,镇静是与 ADR 相关的独立因素(OR:1.49,95% 置信区间:1.35-1.65,P <0.001)。该效应在亚组分析(P > 0.05)和 PSM 分析(ADR:37.6% vs. 29.1%,OR:1.47,95% CI:1.33-1.63,P < 0.001)中一致:结论:在结肠镜检查过程中,镇静与较高的息肉和 ADR 相关,这可以提高结肠镜检查的质量。
{"title":"Sedation Is Associated with Higher Polyp and Adenoma Detection Rates during Colonoscopy: A Retrospective Cohort Study.","authors":"Chenghu Xu, Dehua Tang, Ying Xie, Muhan Ni, Min Chen, Yonghua Shen, Xiaotan Dou, Lin Zhou, Guifang Xu, Lei Wang, Ying Lv, Shu Zhang, Xiaoping Zou","doi":"10.1155/2023/1172478","DOIUrl":"10.1155/2023/1172478","url":null,"abstract":"<p><strong>Background and aims: </strong>Currently sedation is a common practice in colonoscopy to reduce pain of patients and improve the operator satisfaction, whereas its impact on examination quality, especially adenoma detection rate (ADR) is still controversial. Thus, we aimed to investigate the association of sedation with ADR.</p><p><strong>Methods: </strong>Consecutive patients receiving colonoscopy between January 2017 and January 2020 at the Nanjing Drum Tower Hospital, Nanjing, China, were collected. Univariate and multivariate logistic regression models were performed to investigate the association between sedation and ADR. Subgroup analysis and propensity score matching (PSM) analysis, as sensitivity analysis, were performed to validate the independent effect.</p><p><strong>Results: </strong>The ADR was significantly higher in cases with sedation (ADR: 36.9% vs. 29.1%, odds ratio [OR]: 1.42, 95% confidence interval [CI]: 1.31-1.55, <i>P</i> < 0.001). Multivariate analysis showed that the sedation was an independent factor associated with ADR (OR: 1.49, 95% CI: 1.35-1.65, <i>P</i> < 0.001). The effect was consistent in subgroup analyses (<i>P</i> > 0.05) and PSM analysis (ADR: 37.6% vs. 29.1%, OR: 1.47, 95% CI: 1.33-1.63, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>Sedation was associated with a higher polyp and ADR s during colonoscopy, which can promote the quality of colonoscopy.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"1172478"},"PeriodicalIF":2.0,"publicationDate":"2023-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966568/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10862497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Advanced Development and New Horizons. 人工智能在炎症性肠病内窥镜检查中的应用:先进的发展和新的视野。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/3228832
Yu Chang, Zhi Wang, Hai-Bo Sun, Yu-Qin Li, Tong-Yu Tang

Inflammatory bowel disease (IBD) is a complex chronic immune disease with two subtypes: Crohn's disease and ulcerative colitis. Considering the differences in pathogenesis, etiology, clinical presentation, and response to therapy among patients, gastroenterologists mainly rely on endoscopy to diagnose and treat IBD during clinical practice. However, as exemplified by the increasingly comprehensive ulcerative colitis endoscopic scoring system, the endoscopic diagnosis, evaluation, and treatment of IBD still rely on the subjective manipulation and judgment of endoscopists. In recent years, the use of artificial intelligence (AI) has grown substantially in various medical fields, and an increasing number of studies have investigated the use of this emerging technology in the field of gastroenterology. Clinical applications of AI have focused on IBD pathogenesis, etiology, diagnosis, and patient prognosis. Large-scale datasets offer tremendous utility in the development of novel tools to address the unmet clinical and practice needs for treating patients with IBD. However, significant differences among AI methodologies, datasets, and clinical findings limit the incorporation of AI technology into clinical practice. In this review, we discuss practical AI applications in the diagnosis of IBD via gastroenteroscopy and speculate regarding a future in which AI technology provides value for the diagnosis and treatment of IBD patients.

炎症性肠病(IBD)是一种复杂的慢性免疫性疾病,有两种亚型:克罗恩病和溃疡性结肠炎。考虑到患者在发病机制、病因、临床表现、治疗反应等方面的差异,胃肠病学家在临床实践中主要依靠内镜对IBD进行诊断和治疗。然而,以日益完善的溃疡性结肠炎内镜评分系统为例,IBD的内镜诊断、评估和治疗仍然依赖于内镜医师的主观操作和判断。近年来,人工智能(AI)在各个医学领域的应用大幅增长,越来越多的研究调查了这一新兴技术在胃肠病学领域的应用。人工智能的临床应用主要集中在IBD的发病机制、病因、诊断和患者预后方面。大规模数据集为开发新的工具提供了巨大的效用,以解决治疗IBD患者未满足的临床和实践需求。然而,人工智能方法、数据集和临床发现之间的显著差异限制了人工智能技术融入临床实践。在这篇综述中,我们讨论了人工智能在肠胃镜诊断IBD中的实际应用,并推测了人工智能技术在IBD患者诊断和治疗中的未来价值。
{"title":"Artificial Intelligence in Inflammatory Bowel Disease Endoscopy: Advanced Development and New Horizons.","authors":"Yu Chang,&nbsp;Zhi Wang,&nbsp;Hai-Bo Sun,&nbsp;Yu-Qin Li,&nbsp;Tong-Yu Tang","doi":"10.1155/2023/3228832","DOIUrl":"https://doi.org/10.1155/2023/3228832","url":null,"abstract":"<p><p>Inflammatory bowel disease (IBD) is a complex chronic immune disease with two subtypes: Crohn's disease and ulcerative colitis. Considering the differences in pathogenesis, etiology, clinical presentation, and response to therapy among patients, gastroenterologists mainly rely on endoscopy to diagnose and treat IBD during clinical practice. However, as exemplified by the increasingly comprehensive ulcerative colitis endoscopic scoring system, the endoscopic diagnosis, evaluation, and treatment of IBD still rely on the subjective manipulation and judgment of endoscopists. In recent years, the use of artificial intelligence (AI) has grown substantially in various medical fields, and an increasing number of studies have investigated the use of this emerging technology in the field of gastroenterology. Clinical applications of AI have focused on IBD pathogenesis, etiology, diagnosis, and patient prognosis. Large-scale datasets offer tremendous utility in the development of novel tools to address the unmet clinical and practice needs for treating patients with IBD. However, significant differences among AI methodologies, datasets, and clinical findings limit the incorporation of AI technology into clinical practice. In this review, we discuss practical AI applications in the diagnosis of IBD via gastroenteroscopy and speculate regarding a future in which AI technology provides value for the diagnosis and treatment of IBD patients.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"3228832"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9357290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The Usefulness of the Alpha-Retroflex Position in Biliary Cannulation on Single-Balloon Enteroscopy-Assisted Endoscopic Retrograde Cholangiopancreatography in Patients with Roux-en-Y Gastrectomy: A Retrospective Study. 单气囊肠镜辅助内镜逆行胆管造影在Roux-en-Y胃切除术患者胆道插管中的作用:回顾性研究。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/6678991
Hiroo Imazu, Rota Osawa, Koji Yamada, Toshimi Takahashi, Muneo Kawamura, Shuzo Nomura, Suguru Hamana, Noriyuki Kuniyoshi, Mariko Fujisawa, Kei Saito, Hirofumi Kogure

Introduction: Balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (BE-ERCP) is a useful therapeutic procedure that provides promising results in patients with surgically altered anatomy. However, biliary cannulation in BE-ERCP remains challenging. Therefore, in patients with Roux-en-Y gastrectomy, this study aimed to evaluate a BE-ERCP cannulation strategy that includes the newly developed alpha-retroflex scope position.

Methods: This was a retrospective review of 52 patients with Roux-en-Y gastrectomy who underwent BE-ERCP at two centers between April 2017 and December 2022. In these patients, three types of scope position had been used for biliary cannulation: straight (S-position), J-retroflex (J-position), and alpha-retroflex (A-position). First, the S-position was used for biliary cannulation. Then, if biliary cannulation was difficult with this position, the J-position was used, followed by the A-position, if necessary.

Results: The biliary cannulation success rate was 96.6% (50/52). The S-, J-, and A-positions achieved successful biliary cannulation in 24 (48%), 14 (28%), and 12 patients (24%), respectively. No adverse events, including post-ERCP pancreatitis and perforation, occurred.

Conclusion: This was the first study of a cannulation strategy that included the A-position in addition to the S- and J-positions. The study showed that the A-position is feasible and safe in BE-ERCP in patients with Roux-en-Y gastrectomy.

导语:气囊小肠镜辅助内镜逆行胆管造影(BE-ERCP)是一种有用的治疗方法,对手术改变解剖结构的患者提供了有希望的结果。然而,在BE-ERCP中,胆道插管仍然具有挑战性。因此,在Roux-en-Y胃切除术患者中,本研究旨在评估包括新开发的α -反射镜位置在内的BE-ERCP插管策略。方法:回顾性分析2017年4月至2022年12月在两个中心接受Roux-en-Y胃切除术的52例BE-ERCP患者。在这些患者中,使用了三种内镜位置进行胆道插管:直(s位)、j -逆行(j位)和α -逆行(a位)。首先,采用s位胆道插管。然后,如果该体位难以插管,则采用j体位,必要时再采用a体位。结果:胆道插管成功率为96.6%(50/52)。S位、J位和a位分别成功插管24例(48%)、14例(28%)和12例(24%)。没有发生不良事件,包括ercp后胰腺炎和穿孔。结论:这是第一次对除S位和j位外还包括a位的插管策略进行研究。本研究表明,Roux-en-Y胃切除术患者采用a位进行BE-ERCP是可行且安全的。
{"title":"The Usefulness of the Alpha-Retroflex Position in Biliary Cannulation on Single-Balloon Enteroscopy-Assisted Endoscopic Retrograde Cholangiopancreatography in Patients with Roux-en-Y Gastrectomy: A Retrospective Study.","authors":"Hiroo Imazu,&nbsp;Rota Osawa,&nbsp;Koji Yamada,&nbsp;Toshimi Takahashi,&nbsp;Muneo Kawamura,&nbsp;Shuzo Nomura,&nbsp;Suguru Hamana,&nbsp;Noriyuki Kuniyoshi,&nbsp;Mariko Fujisawa,&nbsp;Kei Saito,&nbsp;Hirofumi Kogure","doi":"10.1155/2023/6678991","DOIUrl":"https://doi.org/10.1155/2023/6678991","url":null,"abstract":"<p><strong>Introduction: </strong>Balloon enteroscopy-assisted endoscopic retrograde cholangiopancreatography (BE-ERCP) is a useful therapeutic procedure that provides promising results in patients with surgically altered anatomy. However, biliary cannulation in BE-ERCP remains challenging. Therefore, in patients with Roux-en-Y gastrectomy, this study aimed to evaluate a BE-ERCP cannulation strategy that includes the newly developed alpha-retroflex scope position.</p><p><strong>Methods: </strong>This was a retrospective review of 52 patients with Roux-en-Y gastrectomy who underwent BE-ERCP at two centers between April 2017 and December 2022. In these patients, three types of scope position had been used for biliary cannulation: straight (S-position), J-retroflex (J-position), and alpha-retroflex (A-position). First, the S-position was used for biliary cannulation. Then, if biliary cannulation was difficult with this position, the J-position was used, followed by the A-position, if necessary.</p><p><strong>Results: </strong>The biliary cannulation success rate was 96.6% (50/52). The S-, J-, and A-positions achieved successful biliary cannulation in 24 (48%), 14 (28%), and 12 patients (24%), respectively. No adverse events, including post-ERCP pancreatitis and perforation, occurred.</p><p><strong>Conclusion: </strong>This was the first study of a cannulation strategy that included the A-position in addition to the S- and J-positions. The study showed that the A-position is feasible and safe in BE-ERCP in patients with Roux-en-Y gastrectomy.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"6678991"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421710/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10371429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical Review on Endoscopic Treatment Devices for Management of Upper Gastrointestinal Postsurgical Leaks. 上消化道术后渗漏的内镜治疗装置技术综述。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/9712555
Renato Medas, Eduardo Rodrigues-Pinto

Upper gastrointestinal postsurgical leaks are challenging to manage and often require radiological, endoscopic, or surgical intervention. Nowadays, endoscopy is considered the first-line approach for their management, however, there is no definite consensus on the most appropriate therapeutic approach. There is a wide diversity of endoscopic options, from close-cover-divert approaches to active or passive internal drainage approaches. Theoretically, all these options can be used alone or with a multimodality approach, as each of them has different mechanisms of action. The approach to postsurgical leaks should always be tailored to each patient, taking into account the several variables that may influence the final outcome. In this review, we discuss the important developments in endoscopic devices for the treatment of postsurgical leaks. Our discussion specifically focuses on principles and mechanism of action, advantages and disadvantages of each technique, indications, clinical success, and adverse events. An algorithm for endoscopic approach is proposed.

上消化道术后泄漏是具有挑战性的管理,往往需要放射,内窥镜或手术干预。目前,内窥镜检查被认为是治疗的一线方法,然而,对于最合适的治疗方法没有明确的共识。有多种内镜选择,从封闭转移入路到主动或被动内引流入路。从理论上讲,所有这些选项都可以单独使用,也可以与多模态方法一起使用,因为每个选项都有不同的作用机制。术后渗漏的处理方法应始终针对每位患者,考虑到可能影响最终结果的几个变量。在这篇综述中,我们讨论了内窥镜设备治疗术后泄漏的重要进展。我们的讨论特别集中在原理和作用机制,每种技术的优缺点,适应症,临床成功和不良事件。提出了一种内镜入路算法。
{"title":"Technical Review on Endoscopic Treatment Devices for Management of Upper Gastrointestinal Postsurgical Leaks.","authors":"Renato Medas,&nbsp;Eduardo Rodrigues-Pinto","doi":"10.1155/2023/9712555","DOIUrl":"https://doi.org/10.1155/2023/9712555","url":null,"abstract":"<p><p>Upper gastrointestinal postsurgical leaks are challenging to manage and often require radiological, endoscopic, or surgical intervention. Nowadays, endoscopy is considered the first-line approach for their management, however, there is no definite consensus on the most appropriate therapeutic approach. There is a wide diversity of endoscopic options, from close-cover-divert approaches to active or passive internal drainage approaches. Theoretically, all these options can be used alone or with a multimodality approach, as each of them has different mechanisms of action. The approach to postsurgical leaks should always be tailored to each patient, taking into account the several variables that may influence the final outcome. In this review, we discuss the important developments in endoscopic devices for the treatment of postsurgical leaks. Our discussion specifically focuses on principles and mechanism of action, advantages and disadvantages of each technique, indications, clinical success, and adverse events. An algorithm for endoscopic approach is proposed.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"9712555"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279499/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Dissection for Prepyloric Submucosal Tumors: A Case-Matched Controlled Study. 粘膜下隧道内镜切除与内镜粘膜下剥离治疗幽门前粘膜下肿瘤的比较:病例匹配对照研究。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/5931360
Wengang Zhang, Jiafeng Wang, Ningli Chai, Enqiang Linghu

Objectives: Endoscopic submucosal dissection (ESD) has become a well-established treatment method for gastric submucosal tumors (SMTs). However, there existed some challenges to perform ESD for prepyloric SMTs on account of the special location. Recently, submucosal tunneling endoscopic resection (STER) provided a novel option for prepyloric SMTs. This study aimed to make a comprehensive comparison between prepyloric STER (P-STER) and ESD for the treatment of prepyloric SMTs.

Methods: Patients with prepyloric SMTs undergoing P-STER treatment between January 2016 and October 2021 were retrospectively reviewed and individually matched at 1 : 1 ratio with those with ESD treatment according to lesion size, lesion location, pathologic diagnosis, lesion origin, and surgery date, forming P-STER and ESD group, respectively. A sample size of 12 patients was collected for each group. Treatment outcomes including resection time, en bloc resection rate, complete resection rate, and postoperative hospital stay as well as occurrence of complications were evaluated.

Results: Compared with ESD group, P-STER group got shorter resection time (52.50 minutes for ESD group vs. 38.67 minutes for P-STER group, P = 0.001), shorter postoperative hospital stay (7.00 day for ESD group vs. 5.50 day for P-STER group, P = 0.008), and lower rate of postoperative abdominal pain (50.00% for ESD group vs. 8.33% for P-STER group, P = 0.025). No complication was encountered in P-STER group, whereas one patient with postoperative bleeding was found in ESD group.

Conclusions: For the treatment of prepyloric SMTs, P-STER appeared to be a more effective endoscopic technique compared with ESD, although further randomized controlled trials were warranted.

目的:内镜下粘膜剥离术(ESD)已成为胃粘膜下肿瘤(SMTs)的一种成熟的治疗方法。然而,由于smt的特殊位置,对smt进行ESD存在一些挑战。最近,粘膜下隧道内镜切除术(STER)为幽门前smt提供了一种新的选择。本研究旨在全面比较P-STER与ESD治疗幽门前smt的疗效。方法:回顾性分析2016年1月至2021年10月间接受P-STER治疗的幽门前smt患者,根据病变大小、病变部位、病理诊断、病变来源、手术日期,与接受ESD治疗的患者按1:1比例单独匹配,分别组成P-STER组和ESD组。每组抽取12例患者作为样本。评估治疗结果,包括切除时间、整体切除率、完全切除率、术后住院时间及并发症发生情况。结果:与ESD组相比,P- ster组手术切除时间更短(ESD组52.50 min比P- ster组38.67 min, P = 0.001),术后住院时间更短(ESD组7.00 d比P- ster组5.50 d, P = 0.008),术后腹痛发生率更低(ESD组50.00%比P- ster组8.33%,P = 0.025)。P-STER组无并发症发生,ESD组有1例术后出血。结论:对于幽门前smt的治疗,P-STER似乎是一种比ESD更有效的内镜技术,尽管进一步的随机对照试验是必要的。
{"title":"Comparison between Submucosal Tunneling Endoscopic Resection and Endoscopic Submucosal Dissection for Prepyloric Submucosal Tumors: A Case-Matched Controlled Study.","authors":"Wengang Zhang,&nbsp;Jiafeng Wang,&nbsp;Ningli Chai,&nbsp;Enqiang Linghu","doi":"10.1155/2023/5931360","DOIUrl":"https://doi.org/10.1155/2023/5931360","url":null,"abstract":"<p><strong>Objectives: </strong>Endoscopic submucosal dissection (ESD) has become a well-established treatment method for gastric submucosal tumors (SMTs). However, there existed some challenges to perform ESD for prepyloric SMTs on account of the special location. Recently, submucosal tunneling endoscopic resection (STER) provided a novel option for prepyloric SMTs. This study aimed to make a comprehensive comparison between prepyloric STER (P-STER) and ESD for the treatment of prepyloric SMTs.</p><p><strong>Methods: </strong>Patients with prepyloric SMTs undergoing P-STER treatment between January 2016 and October 2021 were retrospectively reviewed and individually matched at 1 : 1 ratio with those with ESD treatment according to lesion size, lesion location, pathologic diagnosis, lesion origin, and surgery date, forming P-STER and ESD group, respectively. A sample size of 12 patients was collected for each group. Treatment outcomes including resection time, en bloc resection rate, complete resection rate, and postoperative hospital stay as well as occurrence of complications were evaluated.</p><p><strong>Results: </strong>Compared with ESD group, P-STER group got shorter resection time (52.50 minutes for ESD group vs. 38.67 minutes for P-STER group, <i>P</i> = 0.001), shorter postoperative hospital stay (7.00 day for ESD group vs. 5.50 day for P-STER group, <i>P</i> = 0.008), and lower rate of postoperative abdominal pain (50.00% for ESD group vs. 8.33% for P-STER group, <i>P</i> = 0.025). No complication was encountered in P-STER group, whereas one patient with postoperative bleeding was found in ESD group.</p><p><strong>Conclusions: </strong>For the treatment of prepyloric SMTs, P-STER appeared to be a more effective endoscopic technique compared with ESD, although further randomized controlled trials were warranted.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"5931360"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9101410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Screening for Missed Lesions of Synchronous Multiple Early Gastric Cancer during Endoscopic Submucosal Dissection. 内镜下粘膜下夹层夹层中早期同步多发性胃癌漏诊的筛查。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/2824573
Jiangnan Wan, Yi Fang, Haizhong Jiang, Bujiang Wang, Lei Xu, Chunjiu Hu, Honghui Chen, Xiaoyun Ding

Aims: To evaluate the value of endoscopic screening during endoscopic submucosal dissection (ESD) in the detection of synchronous multiple early gastric cancer (SMEGC) and the risk factors for missed diagnosis of SMEGC.

Methods: We conducted gastric endoscopic screening during ESD operation in 271 patients with early gastric cancer (EGC) referred for ESD, and endoscopic follow-up within 1 year after the operation. The detection and characteristics of SMEGC were analyzed in three stages: before ESD, during ESD operation, and within 1 year after ESD.

Results: SMEGC was detected in 37 of 271 patients (13.6%). Among them, 21 patients with SMEGC (56.8%) were diagnosed before ESD, 9 (24.3%) were diagnosed with SMEGC by endoscopic screening during ESD operation, and 7 (18.9%) were found to have EGC lesions in the stomach during postoperative endoscopic follow-up within 1 year. The preoperative missed detection rate of SMEGC was 43.2%, and the rate of missed detection could be reduced by 24.3% (9/37) with endoscopic screening during ESD operation. Missed SMEGC lesions were more common in flat or depressed type and smaller in size than the lesions found before ESD. The presence of severe atrophic gastritis and age ≥60 years were significantly correlated with SMEGC (P < 0.05), while multivariate analysis showed that age ≥60 years was an independent risk factor (OR = 2.63, P < 0.05) for SMEGC.

Conclusions: SMEGC lesions are apt to be missed endoscopically. Special attention should be paid to small, depressed, or flat lesions in detecting SMEGC, especially in elderly patients or (and) patients with severe atrophic gastritis. Endoscopic screening during ESD operation can effectively reduce the missed diagnosis rate of SMEGC.

目的:探讨内镜粘膜下剥离术(ESD)中内镜筛查对同步多发早期胃癌(SMEGC)的诊断价值及漏诊的危险因素。方法:对271例早期胃癌(EGC)行ESD手术的患者在手术期间进行胃内镜筛查,术后1年内进行内镜随访。从ESD前、ESD操作中、ESD后1年内三个阶段分析smigc的检测及特征。结果:271例患者中有37例(13.6%)检出SMEGC。其中,有21例(56.8%)患者在ESD手术前被诊断为SMEGC, 9例(24.3%)患者在ESD手术中经内镜筛查被诊断为SMEGC, 7例(18.9%)患者在术后1年内的内镜随访中发现胃内有EGC病变。SMEGC术前漏检率为43.2%,在ESD手术中进行内镜筛查可使漏检率降低24.3%(9/37)。未发现的SMEGC病变以扁平或凹陷型多见,且比ESD前发现的病变体积小。存在严重萎缩性胃炎、年龄≥60岁与SMEGC有显著相关性(P < 0.05),多因素分析显示年龄≥60岁是SMEGC的独立危险因素(OR = 2.63, P < 0.05)。结论:内镜下易漏诊SMEGC病变。在检测SMEGC时应特别注意小的、凹陷的或扁平的病变,特别是在老年患者或(和)严重萎缩性胃炎患者中。内镜下ESD手术筛查可有效降低smigc的漏诊率。
{"title":"Endoscopic Screening for Missed Lesions of Synchronous Multiple Early Gastric Cancer during Endoscopic Submucosal Dissection.","authors":"Jiangnan Wan,&nbsp;Yi Fang,&nbsp;Haizhong Jiang,&nbsp;Bujiang Wang,&nbsp;Lei Xu,&nbsp;Chunjiu Hu,&nbsp;Honghui Chen,&nbsp;Xiaoyun Ding","doi":"10.1155/2023/2824573","DOIUrl":"https://doi.org/10.1155/2023/2824573","url":null,"abstract":"<p><strong>Aims: </strong>To evaluate the value of endoscopic screening during endoscopic submucosal dissection (ESD) in the detection of synchronous multiple early gastric cancer (SMEGC) and the risk factors for missed diagnosis of SMEGC.</p><p><strong>Methods: </strong>We conducted gastric endoscopic screening during ESD operation in 271 patients with early gastric cancer (EGC) referred for ESD, and endoscopic follow-up within 1 year after the operation. The detection and characteristics of SMEGC were analyzed in three stages: before ESD, during ESD operation, and within 1 year after ESD.</p><p><strong>Results: </strong>SMEGC was detected in 37 of 271 patients (13.6%). Among them, 21 patients with SMEGC (56.8%) were diagnosed before ESD, 9 (24.3%) were diagnosed with SMEGC by endoscopic screening during ESD operation, and 7 (18.9%) were found to have EGC lesions in the stomach during postoperative endoscopic follow-up within 1 year. The preoperative missed detection rate of SMEGC was 43.2%, and the rate of missed detection could be reduced by 24.3% (9/37) with endoscopic screening during ESD operation. Missed SMEGC lesions were more common in flat or depressed type and smaller in size than the lesions found before ESD. The presence of severe atrophic gastritis and age ≥60 years were significantly correlated with SMEGC (<i>P</i> < 0.05), while multivariate analysis showed that age ≥60 years was an independent risk factor (OR = 2.63, <i>P</i> < 0.05) for SMEGC.</p><p><strong>Conclusions: </strong>SMEGC lesions are apt to be missed endoscopically. Special attention should be paid to small, depressed, or flat lesions in detecting SMEGC, especially in elderly patients or (and) patients with severe atrophic gastritis. Endoscopic screening during ESD operation can effectively reduce the missed diagnosis rate of SMEGC.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"2824573"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9318462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Economic Consequences of Surgery for Adhesive Small Bowel Obstruction: A Population-Based Study. 粘连性小肠梗阻手术的经济后果:一项基于人群的研究。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/1844690
Thorbjörn Sakari, Sophie Langenskiöld, Filip Sköldberg, Urban Karlbom

Background and aims: Most patients develop adhesions after abdominal surgery, some will be hospitalized with small bowel obstruction (SBO), and some also require surgery. The operations and follow-up are expensive, but recent data of costs are scarce. The aim of this study was to describe the direct costs of SBO-surgery and follow-up, in a population-based setting. The association between cost of SBO and peri- and postoperative data was also studied.

Methods: In a retrospective cohort study, all patients (n = 402) operated for adhesive SBO in Gävleborg and Uppsala counties (2007-2012) were studied. The median follow-up was 8 years. Costs were calculated according to the pricelist of Uppsala University Hospital, Uppsala, Sweden.

Results: Overall total costs were €16.267 million, corresponding to a mean total cost per patient of €40,467 during the studied period. Diffuse adhesions and postoperative complications were associated with increased costs for SBO in a multivariable analysis (P < 0.001). Most costs, about €14 million (85%), arouse in conjunction with the SBO-index surgery period. In-hospital stay was the dominating cost, accounting for 70% of the total costs.

Conclusion: Surgery for SBO generates substantial economic burden for healthcare systems. Measures that reduce the incidence of SBO, the frequency of postoperative complication, or the length of stay have the potential to reduce this economic burden. The cost estimates from this study may be valuable for future cost-benefit analyses in intervention studies.

背景与目的:大多数患者在腹部手术后出现粘连,部分患者会因小肠梗阻(SBO)住院,部分患者还需要手术治疗。手术和随访费用昂贵,但最近的费用数据很少。本研究的目的是描述以人群为基础的sbo手术和随访的直接成本。SBO成本与围手术期和术后数据之间的关系也被研究。方法:回顾性队列研究,对2007-2012年在Gävleborg和乌普萨拉县(Uppsala county)接受黏附性SBO手术的所有患者(n = 402)进行研究。中位随访时间为8年。根据瑞典乌普萨拉乌普萨拉大学医院的价目表计算费用。结果:总体总成本为1626.7万欧元,相当于研究期间每位患者的平均总成本为40467欧元。在多变量分析中,弥漫性粘连和术后并发症与SBO的成本增加相关(P < 0.001)。大多数费用,约1400万欧元(85%),与sbo指数手术期有关。住院是主要成本,占总成本的70%。结论:SBO手术给医疗系统带来了巨大的经济负担。减少SBO发生率、术后并发症频率或住院时间的措施有可能减轻这一经济负担。本研究的成本估计可能对未来干预研究的成本效益分析有价值。
{"title":"Economic Consequences of Surgery for Adhesive Small Bowel Obstruction: A Population-Based Study.","authors":"Thorbjörn Sakari,&nbsp;Sophie Langenskiöld,&nbsp;Filip Sköldberg,&nbsp;Urban Karlbom","doi":"10.1155/2023/1844690","DOIUrl":"https://doi.org/10.1155/2023/1844690","url":null,"abstract":"<p><strong>Background and aims: </strong>Most patients develop adhesions after abdominal surgery, some will be hospitalized with small bowel obstruction (SBO), and some also require surgery. The operations and follow-up are expensive, but recent data of costs are scarce. The aim of this study was to describe the direct costs of SBO-surgery and follow-up, in a population-based setting. The association between cost of SBO and peri- and postoperative data was also studied.</p><p><strong>Methods: </strong>In a retrospective cohort study, all patients (<i>n</i> = 402) operated for adhesive SBO in Gävleborg and Uppsala counties (2007-2012) were studied. The median follow-up was 8 years. Costs were calculated according to the pricelist of Uppsala University Hospital, Uppsala, Sweden.</p><p><strong>Results: </strong>Overall total costs were €16.267 million, corresponding to a mean total cost per patient of €40,467 during the studied period. Diffuse adhesions and postoperative complications were associated with increased costs for SBO in a multivariable analysis (<i>P</i> < 0.001). Most costs, about €14 million (85%), arouse in conjunction with the SBO-index surgery period. In-hospital stay was the dominating cost, accounting for 70% of the total costs.</p><p><strong>Conclusion: </strong>Surgery for SBO generates substantial economic burden for healthcare systems. Measures that reduce the incidence of SBO, the frequency of postoperative complication, or the length of stay have the potential to reduce this economic burden. The cost estimates from this study may be valuable for future cost-benefit analyses in intervention studies.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"1844690"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9985498/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10866620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-Proximal Jejunostomy Application after McKeown-Type Esophagectomy: A Retrospective Case-Series Study. mckeown型食管切除术后超近端空肠造口术的应用:回顾性病例系列研究。
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/5874332
Dongliang Lin, Zhendong Xu, Jinlong Huang, Wenshan Hong, Weiqing Zhang, Luoyu Lian

Background: Jejunostomy is the main form of enteral nutritional support after McKeown-type esophagectomy. However, this requires the jejunum to be secured to the abdominal wall, which can lead to catheter-related complications. Here, we present a new type of jejunostomy, ultra-proximal jejunostomy, which does not require fixation of the jejunum to the abdominal wall.

Methods: Patients who underwent McKeown-type esophagectomy between January 2021 and March 2022 were included in this study. Postoperative outcomes of patients who underwent ultra-proximal jejunostomy are also presented.

Results: Forty-three patients were able to receive enteral nutritional support via an ultra-proximal jejunostomy after McKeown-type esophagectomy, and no cases of enteral fistulas were observed. The pain in the left lower abdomen largely disappeared after the removal of the jejunostomy tube in all patients, and there was no difficulty in removing the tube. To date, none of these patients have experienced bowel obstruction or jejunal torsion.

Conclusion: An ultra-proximal jejunostomy is a safe and feasible method and a better option for enteral nutrition support after McKeown-type esophagectomy.

背景:空肠造口术是mckeown型食管切除术后肠内营养支持的主要形式。然而,这需要将空肠固定在腹壁上,这可能导致导管相关并发症。在这里,我们提出一种新型的空肠吻合术,超近端空肠吻合术,它不需要将空肠固定在腹壁上。方法:在2021年1月至2022年3月期间接受mckeown型食管切除术的患者纳入本研究。术后结果的病人谁接受超近端空肠造口也提出。结果:43例患者在mckeown型食管切除术后可通过超近端空肠造口获得肠内营养支持,无肠内瘘发生。所有患者切除空肠造口管后,左下腹疼痛基本消失,拔管无困难。迄今为止,这些患者均未发生肠梗阻或空肠扭转。结论:超近端空肠造口是mckeown型食管切除术后肠内营养支持的一种较好的选择,安全可行。
{"title":"Ultra-Proximal Jejunostomy Application after McKeown-Type Esophagectomy: A Retrospective Case-Series Study.","authors":"Dongliang Lin,&nbsp;Zhendong Xu,&nbsp;Jinlong Huang,&nbsp;Wenshan Hong,&nbsp;Weiqing Zhang,&nbsp;Luoyu Lian","doi":"10.1155/2023/5874332","DOIUrl":"https://doi.org/10.1155/2023/5874332","url":null,"abstract":"<p><strong>Background: </strong>Jejunostomy is the main form of enteral nutritional support after McKeown-type esophagectomy. However, this requires the jejunum to be secured to the abdominal wall, which can lead to catheter-related complications. Here, we present a new type of jejunostomy, ultra-proximal jejunostomy, which does not require fixation of the jejunum to the abdominal wall.</p><p><strong>Methods: </strong>Patients who underwent McKeown-type esophagectomy between January 2021 and March 2022 were included in this study. Postoperative outcomes of patients who underwent ultra-proximal jejunostomy are also presented.</p><p><strong>Results: </strong>Forty-three patients were able to receive enteral nutritional support via an ultra-proximal jejunostomy after McKeown-type esophagectomy, and no cases of enteral fistulas were observed. The pain in the left lower abdomen largely disappeared after the removal of the jejunostomy tube in all patients, and there was no difficulty in removing the tube. To date, none of these patients have experienced bowel obstruction or jejunal torsion.</p><p><strong>Conclusion: </strong>An ultra-proximal jejunostomy is a safe and feasible method and a better option for enteral nutrition support after McKeown-type esophagectomy.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"5874332"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10332203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gastrointestinal Infection in South African Children under the Age of 5 years: A Mini Review. 南非5岁以下儿童胃肠道感染:综述
IF 2 4区 医学 Q3 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2023-01-01 DOI: 10.1155/2023/1906782
Tshepo Mafokwane, Appolinaire Djikeng, Lucky T Nesengani, John Dewar, Olivia Mapholi

Objective: To estimate gastroenteritis disease and its etiological agents in children under the age of 5 years living in South Africa.

Methods: A mini literature review of pertinent articles published in ScienceDirect, PubMed, GoogleScholar, and Scopus was conducted using search terms: "Gastroenteritis in children," "Gastroenteritis in the world," Gastroenteritis in South Africa," "Prevalence of gastroenteritis," "Epidemiological surveillance of gastroenteritis in the world," and "Causes of gastroenteritis".

Results: A total of 174 published articles were included in this mini review. In the last 20 years, the mortality rate resulting from diarrhea in children under the age of 5 years has declined and this is influenced by improved hygiene practices, awareness programs, an improved water and sanitation supply, and the availability of vaccines. More modern genomic amplification techniques were used to re-analyze stool specimens collected from children in eight low-resource settings in Asia, South America, and Africa reported improved sensitivity of pathogen detection to about 65%, that viruses were the main etiological agents in patients with diarrhea aged from 0 to 11 months but that Shigella, followed by sapovirus and enterotoxigenic Escherichia coli had a high incidence in children aged 12-24 months. In addition, co-infections were noted in nearly 10% of diarrhea cases, with rotavirus and Shigella being the main co-infecting agents together with adenovirus, enteropathogenic E. coli, Clostridium jejuni, or Clostridium coli.

Conclusions: This mini review outlines the epidemiology and trends relating to parasitic, viral, and bacterial agents responsible for gastroenteritis in children in South Africa. An increase in sequence-independent diagnostic approaches will improve the identification of pathogens to resolve undiagnosed cases of gastroenteritis. Emerging state and national surveillance systems should focus on improving the identification of gastrointestinal pathogens in children and the development of further vaccines against gastrointestinal pathogens.

目的:了解南非5岁以下儿童胃肠炎疾病及其病原。方法:通过检索词:“儿童胃肠炎”、“世界胃肠炎”、“南非胃肠炎”、“胃肠炎患病率”、“世界胃肠炎流行病学监测”和“胃肠炎病因”,对ScienceDirect、PubMed、GoogleScholar和Scopus上发表的相关文章进行小型文献综述。结果:这篇小型综述共纳入174篇已发表的文章。在过去20年里,5岁以下儿童因腹泻导致的死亡率有所下降,这是由于卫生习惯的改善、提高认识方案、水和卫生设施供应的改善以及疫苗的可用性。更现代的基因组扩增技术用于重新分析从亚洲、南美洲和非洲八个资源贫乏地区收集的儿童粪便标本,报告病原体检测的敏感性提高到约65%,病毒是0至11月龄腹泻患者的主要病因,但志贺氏菌,其次是萨普病毒和产肠毒素的大肠杆菌在12-24月龄儿童中发病率高。此外,近10%的腹泻病例共感染,轮状病毒和志贺氏菌是主要的共感染源,腺病毒、肠致病性大肠杆菌、空肠梭菌或大肠梭菌是主要的共感染源。结论:这篇小型综述概述了南非儿童胃肠炎的流行病学和趋势,包括寄生虫、病毒和细菌病原体。序列独立诊断方法的增加将提高病原体的识别,以解决未确诊的肠胃炎病例。新兴的州和国家监测系统应侧重于改进儿童胃肠道病原体的鉴定和开发针对胃肠道病原体的进一步疫苗。
{"title":"Gastrointestinal Infection in South African Children under the Age of 5 years: A Mini Review.","authors":"Tshepo Mafokwane,&nbsp;Appolinaire Djikeng,&nbsp;Lucky T Nesengani,&nbsp;John Dewar,&nbsp;Olivia Mapholi","doi":"10.1155/2023/1906782","DOIUrl":"https://doi.org/10.1155/2023/1906782","url":null,"abstract":"<p><strong>Objective: </strong>To estimate gastroenteritis disease and its etiological agents in children under the age of 5 years living in South Africa.</p><p><strong>Methods: </strong>A mini literature review of pertinent articles published in ScienceDirect, PubMed, GoogleScholar, and Scopus was conducted using search terms: \"Gastroenteritis in children,\" \"Gastroenteritis in the world,\" Gastroenteritis in South Africa,\" \"Prevalence of gastroenteritis,\" \"Epidemiological surveillance of gastroenteritis in the world,\" and \"Causes of gastroenteritis\".</p><p><strong>Results: </strong>A total of 174 published articles were included in this mini review. In the last 20 years, the mortality rate resulting from diarrhea in children under the age of 5 years has declined and this is influenced by improved hygiene practices, awareness programs, an improved water and sanitation supply, and the availability of vaccines. More modern genomic amplification techniques were used to re-analyze stool specimens collected from children in eight low-resource settings in Asia, South America, and Africa reported improved sensitivity of pathogen detection to about 65%, that viruses were the main etiological agents in patients with diarrhea aged from 0 to 11 months but that <i>Shigella</i>, followed by sapovirus and enterotoxigenic <i>Escherichia coli</i> had a high incidence in children aged 12-24 months. In addition, co-infections were noted in nearly 10% of diarrhea cases, with rotavirus and <i>Shigella</i> being the main co-infecting agents together with adenovirus, enteropathogenic <i>E. coli</i>, <i>Clostridium jejuni</i>, or <i>Clostridium coli</i>.</p><p><strong>Conclusions: </strong>This mini review outlines the epidemiology and trends relating to parasitic, viral, and bacterial agents responsible for gastroenteritis in children in South Africa. An increase in sequence-independent diagnostic approaches will improve the identification of pathogens to resolve undiagnosed cases of gastroenteritis. Emerging state and national surveillance systems should focus on improving the identification of gastrointestinal pathogens in children and the development of further vaccines against gastrointestinal pathogens.</p>","PeriodicalId":12597,"journal":{"name":"Gastroenterology Research and Practice","volume":"2023 ","pages":"1906782"},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10524623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology Research and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1